- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05149417
Effect of Telemedecine on Post -Trauma Pain Medication Adherence .
Effect of Telemedecine on Post-trauma Pain Medication Adherence After Discharge From Emergency Departement
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This is a prospective, multicenter, randomized trial . Participants are recruited from the emergency departement of Fattouma Bourguiba Monastir.
This study is a seven day three-arm parallel group trial . Participants inculded are aged more than 16 years old who presented to the ED for minor trauma and discharged with analgesic treatment. They are randomized to one of two trial TM intervention groups (SMS and TM) or usual care group (control) in a 1 :1 :1 allocation ratio.
For all inculded patients, demographic characteristics were collected as well as clinical examination findings. The interventional care provided at the ED was mentioned. At ED discharge the pain Visual Analogue Scale (VAS) was evaluated and the analgesic treatment prescribed was noted.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Monastir, Tunisia, 5000
- Fattouma Bourguiba Monastir University Hospital Center
-
Monastir, Tunisia, 5000
- Fattouma bourguiba university hospital of Monastir
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age >16 years old with minor trauma and discharged with an analgesic treatment.
- Included patients should have regular access to a mobile phone ,were able to interact with SMS or could do so with help of a relative.
- Patients who accepted to participate to the study.
- No contraindication to analgesic medication
Exclusion Criteria:
- Swallowing disorder or inability to swallow.
- Unsuitable for follow-up.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Standard group
Patients enrolled in this group were discharged and they didn't undergo any intervention within the treatment period.
|
Patients received a phone call on day 2 and day 4 to evaluate the adherence , to detect any problem that can affect the adherence to the treatment and modify the analgesic protocol treatment if needed.
|
|
Active Comparator: SMS group
patients received SMS at day 2 , day 4 and day 7 after emergency departement discharge to remind them to take their treatment .
|
patients received SMS at day 2 , day 4 and day 7 after emergency departement discharge to remind them to take their treatment .
|
|
Active Comparator: telemonitoring group
Patients received a phone call on day 2 and day 4 to evaluate the adherence , to detect any problem that can affect the adherence to the treatment and modify the analgesic protocol treatment if needed.
|
Patients received a phone call on day 2 and day 4 to evaluate the adherence , to detect any problem that can affect the adherence to the treatment and modify the analgesic protocol treatment if needed.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Visual analog scale after 7 days of follow-up
Time Frame: at seven day after ED discharge .
|
Patient's adherence to analgesics treatment which was assessed by calling patients or by sending SMS in day 2, day 4,and day 7 in SMS group and the telemonitoring group respectively.
|
at seven day after ED discharge .
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Likert scale
Time Frame: at seven day post ED discharge .
|
Patients' satisfaction which was assessed through likert scale.
minimum=1(strongly disagree) , maximum=5 (strongly agree)
|
at seven day post ED discharge .
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- Telemedecine /Adherence
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.